TICKERNERD
Menu
USNAUSNAConsumer Defensive · Packaged Foods

USNA Stock Forecast: USANA Health Sciences, Inc. Price Predictions for 2026-2027

Last close, 18 Sept 2026
$14
−1.39% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 71 of 100 as at 19 Sept 2026 — in the upper half. Here, the model and the Street point the same way.

Market cap
$261.3M
Ticker Nerd rank
71 / 100
Median analyst target
$25
Analysts covering
0
Revenue$223.3M−5.3% y/y
Operating income$9.1M
Net income−$28.0M
Free cash flow$20.2M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−5.9%
1M
+7.0%
YTD
−28.0%
1Y
−54.2%
From 52W high
−54.2%
From 52W low
+10.0%
$13
$31
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

USNA stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores USANA Health Sciences, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 19 Sept 2026
71 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Value
99
Accruals
85
Volatility
82
Quality
72
Issuance
71
Size
64
Growth
43
Revisions
32
Momentum
13

Value (99): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.

Momentum (13): The shares have been drifting down relative to others.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

USNA stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on USNA, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$15$20$25$30Oct 25Jan 26Apr 26Jul 26USNAHigh $25Median $25Low $25

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

Recent analyst actionsNewest first
DateFirmActionRatingTarget
27 Feb 2025DA DavidsonMaintainsNeutral$38 → $36
27 Feb 2025DA DavidsonMaintainsNeutral—
2 Jan 2025DA DavidsonMaintainsNeutral—
23 Oct 2024DA DavidsonMaintainsNeutral—
25 July 2024DA DavidsonMaintainsNeutral—
7 May 2024DA DavidsonMaintainsNeutral—
22 Feb 2024DA DavidsonMaintainsNeutral—
25 Oct 2023DA DavidsonMaintainsNeutral—
26 Apr 2023DA DavidsonMaintainsNeutral—
13 Feb 2023DA DavidsonMaintainsNeutral—
27 Oct 2022DA DavidsonMaintainsNeutral—
28 July 2022DA DavidsonMaintainsNeutral—
12 July 2022DA DavidsonMaintainsNeutral—
7 July 2022JefferiesDowngradeUnderperform—
27 Apr 2022DA DavidsonMaintainsNeutral—
14 Apr 2022DA DavidsonInitiatesNeutral—
10 Feb 2021Roth CapitalMaintainsBuy—
17 Dec 2020Roth CapitalInitiatesBuy—
22 Aug 2019JefferiesInitiatesHold—
3 July 2019Sidoti & Co.DowngradeNeutral—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. USNA appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

USNA vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 18 Sept 2026, USANA Health Sciences, Inc. returned −54.2% against +16.3% for the S&P 500, dividends included.

USNA vs S&P 500, last 12 monthsTotal return, rebased to 100
406080100120Oct 25Jan 26Apr 26Jul 26USNAS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

USNA analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
−64.2%
Analysts raising
0
Analysts cutting
1
Fundamentals

USANA Health Sciences, Inc. (USNA) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
27.3×

Cheaper than 28% of US stocks

Price / sales
0.3×

Cheaper than 89% of US stocks

Price / book
0.5×

Cheaper than 85% of US stocks

EV / EBITDA
1.9×

Cheaper than 57% of US stocks

Growth & margins
Revenue growth (YoY)
−5.3%

Higher than 20% of US stocks

Earnings growth (YoY)
−5.3%

Higher than 30% of US stocks

Gross margin
78.3%

Higher than 90% of US stocks

Operating margin
4.1%

Higher than 53% of US stocks

Net margin
−2.4%

Higher than 27% of US stocks

Returns & dividend
Return on equity
−5.1%

Higher than 39% of US stocks

Return on assets
3.6%

Higher than 69% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

USANA Health Sciences, Inc. (USNA) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • USANA Health Sciences, Inc. has a market value of $261.3M and an enterprise value of $137.4M.

  • Revenue in the twelve months to 30 June 2026: $913.4M. The latest quarter shrank 5.3% year on year.

  • Net income over the same four quarters: −$29.2M, a −3.2% net margin.

  • Diluted earnings per share, trailing twelve months: $−1.21.

  • Free cash flow in the twelve months to 30 June 2026: $15.9M.

  • USANA Health Sciences, Inc. spent $0.0 on share buybacks in the twelve months to 30 June 2026.

  • Shares outstanding: 18.5M.

  • Trailing P/E: 27.3×; forward P/E: 8.0× — the forward figure prices analyst consensus estimates, not reported earnings.

  • USANA Health Sciences, Inc. employs 1,570 people — $582K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 19 Sept 2026

Data provided by Twelve Data

Peers

USNA vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelPackaged Foods
CompanyMarket capTKN rank
USNAUSANA Health Sciences, Inc.$261.3M
71
NAGENiagen Bioscience, Inc.$236.6M
54
BRCCBRC, Inc.$234.3M
75
BGSB&G Foods, Inc.$230.3M
60
NATRNature's Sunshine Products, Inc.$227.8M
84
BYNDBeyond Meat, Inc.$197.9M
34
LWAYLifeway Foods, Inc.$362.1M
37

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own USANA Health Sciences, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest USNA news & analysis

Implied Volatility Surging for USANA Health Stock Options

Zacks Investment Research · 14 Sept 2026neutral

Implied volatility has been surging for USANA Health Sciences (USNA) options, drawing attention to movements in the options market. The article suggests investors should pay close attention to USNA stock based on these recent options-market developments.

Why it matters — A USNA watcher would care because rising implied volatility in the options market can signal shifting expectations among traders about the stock's future price movements.

Protein Pop Launches Protein Pop Balance, a Clear Prebiotic Soda with 15 Grams of Protein and 5 Grams of Fiber

PRNewsWire · 3 Sept 2026neutral

Rise Wellness announced the launch of Protein Pop Balance, a clear prebiotic soda containing 15 grams of protein and 5 grams of fiber, adding the new product to its Protein Pop lineup of ready-to-drink protein beverages.

Why it matters — USNA watchers may note competitive activity in the ready-to-drink protein beverage segment, which overlaps with USANA's health and nutrition product offerings.

USANA CEO Kevin Guest Calls on People to Find a Way to Serve Others, Then Act

PRNewsWire · 1 Sept 2026neutral

USANA Health Sciences Chairman and CEO Kevin Guest issued a public challenge encouraging people to make service a more intentional part of their lives by finding someone who needs help and then acting on it. The announcement was made via press release from Salt Lake City.

Why it matters — The CEO's public call to action reflects USANA's corporate messaging and leadership focus, offering watchers insight into the company's public engagement and brand positioning.

USANA Introduces 3-in-1 Protein, Creatine, and Electrolyte Drink Mix

PRNewsWire · 17 Aug 2026positive

USANA Health Sciences announced the launch of Clear Protein + Creatine Mix, a new 3-in-1 drink combining 10 g of protein, 5 g of creatine, and 600+ mg of electrolytes in a 50-calorie serving. The product is designed to simplify active adults' routines by replacing separate protein, creatine, and hydration products.

Why it matters — A USNA watcher would care because the new product launch expands the company's active-nutrition portfolio and could support its product lineup in the competitive sports nutrition market.

Why Usana Health Sciences Stock Plummeted This Week

The Motley Fool · 9 Aug 2026negative

Usana Health Sciences reported second-quarter earnings and sales that came in well below expectations. The company now expects to record a loss for the full year.

Why it matters — A full-year loss forecast and below-expectation quarterly results signal a meaningful deterioration in Usana's near-term financial outlook for shareholders and prospective investors.

FAQ

Frequently asked questions about USNA stock

How does Ticker Nerd's model rank USNA?

As at 19 Sept 2026, USANA Health Sciences, Inc. ranks 71 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (99 of 100).

What is the USNA stock forecast for 2030?

No analyst covering USANA Health Sciences, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for USNA are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $25 to $25 over the next 12 months.

How has USNA stock performed over the past year?

USANA Health Sciences, Inc. returned -54.2% over the 12 months to 18 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does USANA Health Sciences, Inc. do?

USANA Health Sciences Inc. is a direct-selling health and wellness company that develops, manufactures, and distributes science-based nutritional supplements, healthy foods, and personal care products.

What is the latest news on USNA?

The most recent item we track (Zacks Investment Research, 14 Sept 2026): "Implied Volatility Surging for USANA Health Stock Options". Implied volatility has been surging for USANA Health Sciences (USNA) options, drawing attention to movements in the options market. The article suggests investors should pay close attention to USNA stock based on these recent options-market developments.

Company

About USANA Health Sciences, Inc.

USANA Health Sciences Inc. is a direct-selling health and wellness company that develops, manufactures, and distributes science-based nutritional supplements, healthy foods, and personal care products. USANA Health Sciences Inc. serves consumers through a network of independent distributors and direct-to-consumer channels, offering products that support daily nutrition, active lifestyles, weight management, and skincare. Its portfolio includes nutritional optimizers, vitamin and mineral formulas, meal-replacement products, probiotics, omega-based supplements, and skincare regimens designed for a variety of personal care needs. The company also operates a children’s wellness business through Hiya, broadening its reach in family nutrition. With operations across Asia Pacific, the Americas, and Europe, USANA Health Sciences Inc. plays a role in the global consumer health market by combining in-house product development, manufacturing, and international distribution.

CEO Mr. Kevin G. Guest · 1,570 employees · United States · https://www.usana.com